Minister @DrZweliMkhize committs to uploading MAC Vaccine ADVISORIES by end of briefing. Commits to urgency and expediting availability.

#Vaccines
#nocovidmonopolies

#1Country1Plan

Aim for 67% of population. First HCWs, then elderly and those with co-morbidities.
Mainly COVAX. Balance of funds being secured from govt. when 'COVAX delivers'.
Aiming for earlier date than COVAX. Depends on bilat negotiations with phrma. No DRUG Company has CONFIRMED.
Medical schemes being included and through PMBs (amending reg.ns), public-private initiatives being set up. Task Team/s set up for medical schemes and govt and priv sector (BUSA).
3 funding sourcees: Govt., Medical Schemes, Priv. Sector.
NDAs signed by Govt. with drug companies for several bi-lateral negotiations (I BET NO PATENT LIFTING...).
Working with @SAHPRA1 for early fast track approval of vaccines for 'urgent attention'.
Distrbution structures being set up at district level. With CSOs and traditional structures. !
@tianjohnson
Deal with misconceptions around vaccine hesitancy.
Dealing*
President @PresidencyZA @CyrilRamaphosa also has Africa Vaccine Acquisition Task Team (AVATT) which Min appears to now also sit on...
Minister has been personally involved in some discussions with phrma.
President has reached out to stakeholders in Africa to look at how 'manufacturers' play their part to assist (closest ref to phrma power).
That we and continent 'not get left behind', 'we are working behind the scenes'.
PPP TASK TEAM - with private sector - to secure $ funding for 67% vaccination aim.
I am in despair, even in THIS PANDEMIC, our government is unable to ensure no patent restrictions-does not seem like it is going that way at all so far in this briefing. Grateful for a few temp. deals, but global south is a time bomb, world needs rapid scale up of manufacturing😪
And then this: Spot the outlier...
And of course, the current speaker, wrote this today:

https://t.co/AcG6APtmsZ
Shem, civil society - we only NB to 'make communities understand' - for door to door...
DDG (why is DG not presenting?) says 3 ways to give out a vaccine (that we still waiting for abd will pay who knows what): https://t.co/kWnBgb6Gsr based,
2.outreach / mobile, PHCs
3.vaccination centres for remote areas too.
And then, here we go: it ALL 'DEPENDS ON SUPPLIES - IF AVAILABLE'.
May use s21 special use, and looking at expedited approval with @SAHPRA1 - not all drug co sent data
May use emergency procurement (read: we may pay what phrma wants us to pay...
-where is @CompComSA to review prices BEFORE? OTHERWISE PANDEMIC gouging will happen).
Phrma negotiations/ many meetings: China, India, Pfizer, AstraZ, Cipla?, Moderna, JandJ.

(NDAs with public money is shameful!)
I ain't tweeting all of this...so here is a photo: 😷
Ah CIPLAnow makes sense- SERUM/ @AstraZeneca @UniofOxford - but *tiered
pricing* (WATCH)
@JNJNews @aspenpharma (seems DDG pushing this one)
I think he just said @moderna_tx is acting silly ... (was it someone else?) 🔊🔊🔊
COVAX - THE BLACK BOX -
So, we wait (not critique).
And expect 2nd Q 2021.

(Hence, deadline as I said before, was a big fat red herring...)
???

Who pays the COVAX balance of payment?

Where are the many women business leaders?

So we not pursuing price control or patent restrictions - phrma triumphs?
Hayibo!!!!
Wait- did we just convince @GovernmentZA on #1Country1Plan -so with a single, equitable allocation systemwhere med schemes cannot ALLOCATE in parallel?!!

Oh my.
So much info shared this evening, though alot being kept under wrap and by drug co. NDAs.

Why coudn't @GovernmentZA simply reply *in writing* to a letter asking these very questions from mid-Nov 2020 by @HealthJusticeIn ...major state capacity issues...
Our recourse against phrma will now it seema be at the @CompComSA for price examination, given public funding of several of these potential vaccine candidates. #nocovidmonopolies
#nopandemicgouging
Good thing @HealthJusticeIn & @ezintsha in JULY 2020 asked that @CompComSA work out pre-emptive price regulation of COVID19 products (so that we don't wait *after* deals signed).
Over to drug companies to PROVE PRICE IS CORRECT. Share data & either way, remember Dischem/Babelegi.
Did not fully understand answer on Russia / Sputnik.
Good for @DrZweliMkhize to mention and appreciate public's anxiety and uncertainty - not getting angry or defensive.

Hope @HealthZA gives a briefing every 3 to 5 days until roll out is complete.

We need info, not whispers...

@GCISMedia
We have NO price control over COVAX, as a MIC, we are at the mercy of the COVAX BOARD, a private foundation, no transparency at all.
Big black box.
Cost: approx ZAR 2 BILL.
Minister:
NO JUSTIFICATION for rich countries to hoard vaccines, 'release it'. And 'we fight behind the scenes'.
Come on, say to drug companies to *not profit* in a pandemic. It is OUR public money.
@PresidencyZA may still phone some companies and say 'come on'!

I hope @pfizer @JNJNews @aspenpharma @CiplaRSA @AstraZeneca @UniofOxford @BioNTech_Group and others are listening.

South Africans are tired of waiting, of paying too much, of being blocked.

Salute HCWs.
NOT A SINGLE MENTION THAT @GovernmentZA is also leading a TRIPS WAIVER REQUEST IN GENEVA asking for global IP RULES to be waived in this pandemic...

@HealthZA
@the_dti

Why?
These drug companies have out negotiatiated so many countries, even ours, NDAs aside, so shameful, even COVAX allows this...

We did warn. Months ago.
I am as confused as everyone else about the role of GEMS and Parmed and Polmed in vaccine procurement, distribution and allocation...
Ends with nothing material on TRIPS WAIVER status quo...

Over and out. 😷⏳🧩🧩🧩
Oh wait 😷😷😷
... seems like we did get #1country1plan through agreed upon national allocation *approach* that follows a triage system...

(Not a plan, cos I don't see it in writing, nor tabled in @ParliamentofRSA ! )

At present, slides and national presser.

So @CompComSA most def needs an urgent COVID-19 Vaccine (internal) premptive pricing task team.
Help out at @HealthZA and
@SAHPRA1

Laws needed to PRICE ASSESS BEFORE WE SPEND THE MONEY.

Justify the price, or price variations. Prove it is low or no profit. And, not time bound.
The MAC Vaccine + ADVISORIES are now uploaded by @HealthZA :

https://t.co/QmcB3OboWU
And we still don't know the opposition parties views on IP AND PATENT monopolies. Do they support the status quo?

More from Health

Some thoughts on this: Firstly, it might be personal preference, but I am not keen on this kind of campaign as I feel like it trivialises cancer. Sometimes the serious message gets lost because people are sharing pics of cats or whatever and the important context is gone.


More importantly, the statistic being used in the campaign is misleading. It says 57% of women put off cervical screening if they can't get waxed. But on further investigation, that's not accurate.

The page here goes on to say "57% of women who regularly have their pubic hair professionally removed would put off attending their cervical screening appointment if they hadn’t been able to visit a beauty salon."

So the 57% represents a concern not across the whole population of women, but only those who regularly get waxed. So how big of an issue is this across the whole population? And what else is stopping people getting smears?

I think campaigns for cancer screening are really tricky because there is so much nuance that often doesn't fit into a catchy headline or hashtag. It's certainly not easy and is part of a bigger conversation.

You May Also Like

"I lied about my basic beliefs in order to keep a prestigious job. Now that it will be zero-cost to me, I have a few things to say."


We know that elite institutions like the one Flier was in (partial) charge of rely on irrelevant status markers like private school education, whiteness, legacy, and ability to charm an old white guy at an interview.

Harvard's discriminatory policies are becoming increasingly well known, across the political spectrum (see, e.g., the recent lawsuit on discrimination against East Asian applications.)

It's refreshing to hear a senior administrator admits to personally opposing policies that attempt to remedy these basic flaws. These are flaws that harm his institution's ability to do cutting-edge research and to serve the public.

Harvard is being eclipsed by institutions that have different ideas about how to run a 21st Century institution. Stanford, for one; the UC system; the "public Ivys".